[Federal Register Volume 76, Number 239 (Tuesday, December 13, 2011)]
[Notices]
[Page 77479]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2011-31935]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF COMMERCE

Foreign-Trade Zones Board

[Docket T-6-2011]


Foreign-Trade Zone 7--Mayaguez, PR; Application for Temporary/
Interim Manufacturing Authority; Baxter Healthcare of PR 
(Pharmaceutical and Nutritional Intravenous Bags and Administration 
Sets); Aibonito and Jayuya, PR

    An application has been submitted to the Executive Secretary of the 
Foreign-Trade Zones Board (the Board) by the Puerto Rico Industrial 
Development Company, grantee of FTZ 7, requesting temporary/interim 
manufacturing (T/IM) authority at two sites within FTZ 7 at the Baxter 
Healthcare of Puerto Rico (Baxter) facilities, located in Aibonito and 
Jayuya, Puerto Rico. The application was filed on December 6, 2011.
    The Baxter facilities (200 million unit capacity) are used for the 
manufacture of pharmaceutical and nutritional intravenous (I.V.) bags 
and related components. Under T/IM procedures, Baxter has requested 
authority to produce filled pharmaceutical and nutritional I.V. bags 
(HTSUS 3004.20, 3004.40, 3004.50, 3004.90--duty rate: free) and I.V. 
administration sets and their components (HTSUS 9018.90--duty rate: 
free). Foreign materials that would be used in production (representing 
9% of the value of the finished product) include: Foil pouches (HTSUS 
3923.29), ABS resin (HTSUS 3903.30), L-tryptophan (HTSUS 2933.99), 
glutamic acid (HTSUS 2922.42), N-Acetyl-L-Tyrosine (HTSUS 2924.29) and 
L-Lysine-Acetate (HTSUS 2922.41) (duty rates range: 3-6.5%). T/IM 
authority could be granted for a period of up to two years.
    FTZ procedures could exempt Baxter from customs duty payments on 
the foreign components used in export production. The company 
anticipates that some 22 percent of the facilities' shipments of I.V. 
administration sets and components will be exported. On its domestic 
sales, Baxter would be able to choose the duty rate during customs 
entry procedures that applies to filled I.V. products and 
administration sets (duty rate: free) for the foreign inputs noted 
above. Baxter could also be exempt from duty payments on foreign 
materials that become scrap or waste during the production process.
    In accordance with the Board's regulations, Diane Finver of the FTZ 
Staff is designated examiner to evaluate and analyze the facts and 
information presented in the application and case record and to report 
findings and recommendations pursuant to Board Orders 1347 and 1480.
    Public comment is invited from interested parties. Submissions 
(original and 3 copies) shall be addressed to the Board's Executive 
Secretary at the following address: Office of the Executive Secretary, 
Foreign-Trade Zones Board, U.S. Department of Commerce, Room 2111, 1401 
Constitution Ave. NW., Washington, DC 20230. The closing period for 
their receipt is January 12, 2012.
    Baxter has also submitted a request to the FTZ Board for FTZ 
manufacturing authority beyond a two-year period. It should be noted 
that the request for extended authority is being docketed separately 
and will be processed as a distinct proceeding. Any party wishing to 
submit comments for consideration regarding the request for extended 
authority would need to submit such comments pursuant to the separate 
notice that will be published for that request.
    A copy of the application will be available for public inspection 
at the Office of the Foreign-Trade Zones Board's Executive Secretary at 
the address listed above, and in the ``Reading Room'' section of the 
Board's Web site, which is accessible via http://www.trade.gov/ftz. For 
further information, contact Diane Finver at [email protected], 
(202) 482-1367.

    Dated: December 6, 2011.
Andrew McGilvray,
Executive Secretary.
[FR Doc. 2011-31935 Filed 12-12-11; 8:45 am]
BILLING CODE P